Department of Clinical Microscopy, Faculty of Allied Health Sciences, Chulalongkorn University, Bangkok, Thailand.
Mahidol-Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand.
Malar J. 2020 May 27;19(1):193. doi: 10.1186/s12936-020-03259-9.
Rapid diagnostic tests (RDTs) have become the most common diagnostic tool for detection of Plasmodium falciparum malaria, in particular in remote areas. RDT blood spots provide a source of parasite DNA for molecular analysis. In this study, the utility of RDTs for molecular analysis and the performance of different methods for whole genome amplification were investigated.
Positive P. falciparum RDTs were collected from Kayin, Myanmar from August 2014 to January 2016. The RDT samples were stored for 6 months, 9 months, 20 months, 21 months, and 32 months before DNA extraction and subsequent molecular analysis of P. falciparum kelch 13 (pfkelch13) mutations, P. falciparum multidrug resistance 1 (pfmdr1), and P. falciparum plasmepsin 2 (pfplasmepsin2) gene amplification. In addition, performance of four whole genome amplification (WGA) kits were compared, including REPLI-g, MALBAC, PicoPLEX, and GenomePlex, for which DNA quantity and quality were compared between original DNA and post-WGA products.
The proportion of successful amplification of the different molecular markers was similar between blood spots analysed from RDTs stored for 6, 9, 20, 21, or 32 months. Successful amplification was dependent on the molecular markers fragment length (p value < 0.05): 18% for a 1245 bp fragment of pfkelch13, 71% for 364 bp of pfkelch13, 81% for 87 bp of pfmdr1, 81% for 108 bp of pfplasmepsin2. Comparison of the four WGA assay kits showed that REPLI-g, MALBAC, and PicoPLEX increased the quantity of DNA 60 to 750-fold, whereas the ratio of parasite DNA amplification over human DNA was most favourable for MALBAC. Sequencing results of pfkelch13, P. falciparum chloroquine resistance transporter (pfcrt), P. falciparum dihydrofolate reductase (pfdhfr) and six microsatellite markers assessed from the post-WGA product was the same as from the original DNA.
Blood spots from RDTs are a good source for molecular analysis of P. falciparum, even after storage up to 32 months. WGA of RDT-derived parasite DNA reliably increase DNA quantity with sufficient quality for molecular analysis of resistance markers.
快速诊断检测(RDT)已成为检测恶性疟原虫疟疾的最常用诊断工具,尤其是在偏远地区。RDT 血斑为寄生虫 DNA 的分子分析提供了来源。本研究调查了 RDT 用于分子分析的效用以及不同全基因组扩增方法的性能。
从 2014 年 8 月至 2016 年 1 月在缅甸克伦邦收集了 RDT 阳性恶性疟原虫。在进行 DNA 提取和随后的恶性疟原虫 Kelch13(pfkelch13)突变、恶性疟原虫多药耐药 1(pfmdr1)和恶性疟原虫原浆小体 2(pfplasmepsin2)基因扩增的分子分析之前,RDT 样本分别储存了 6 个月、9 个月、20 个月、21 个月和 32 个月。此外,比较了四种全基因组扩增(WGA)试剂盒,包括 REPLI-g、MALBAC、PicoPLEX 和 GenomePlex,比较了原始 DNA 和 WGA 产物之间的 DNA 数量和质量。
储存 6、9、20、21 或 32 个月的 RDT 分析血斑中不同分子标记的成功扩增比例相似。成功扩增取决于分子标记片段长度(p 值<0.05):pfkelch13 的 1245 bp 片段为 18%,pfkelch13 的 364 bp 片段为 71%,pfmdr1 的 87 bp 片段为 81%,pfplasmepsin2 的 108 bp 片段为 81%。四种 WGA 检测试剂盒的比较表明,REPLI-g、MALBAC 和 PicoPLEX 将 DNA 数量增加了 60 到 750 倍,而 MALBAC 对寄生虫 DNA 扩增与人 DNA 之比最有利。从 WGA 产物中评估的 pfkelch13、恶性疟原虫氯喹耐药转运蛋白(pfcrt)、恶性疟原虫二氢叶酸还原酶(pfdhfr)和六个微卫星标记的测序结果与原始 DNA 相同。
RDT 血斑是恶性疟原虫分子分析的良好来源,即使储存长达 32 个月。RDT 衍生寄生虫 DNA 的 WGA 可可靠地增加 DNA 数量,并具有足够的质量用于耐药标记物的分子分析。